Research & Development

Leading the Future of Stem Cell & Genomic Research

About Our R&D

Driving Innovation in Stem Cell Research for Future Healthcare

We advance stem cell science and regenerative therapies with precision, care, and clinical relevance. Our research supports the next generation of personalized medicine and biotechnology.

Step Inside Our World-Class Stem Cell Lab

We’re proud to collaborate with the Marga and Walter Boll Laboratory at the University Hospital of Cologne to advance cardiovascular research using iPSC technology. This landmark study explores new treatment possibilities for myocardial infarction, marking a notable initiative in the UAE.

Culturing Induced Pluripotent Stem Cells (iPSCs)

iPSCs are mature cells that have been reprogrammed to a stem-like state. Our collaboration with the FSG and the Marga and Walter Boll Laboratory in Germany marks a significant milestone in advancing iPSC research within the UAE.

Day 1

Cells are seeded and begin adhering to the culture plate surface.

Day 1

Cells are seeded and begin adhering to the culture plate surface.

Day 2

Early proliferation begins, with distinct colony formation becoming visible.

Day 3

Noticeable increase in cell density, indicating active and healthy growth.

Day 3

Noticeable increase in cell density, indicating active and healthy growth.

Day 4

Cells reach confluency with well-defined morphology and structure.
Ensuring Precision in iPSC Analysis
Our advanced flow cytometry techniques confirm iPSC quality by comparing stained and unstained samples. This process enables precise identification and characterization of pluripotent stem cells, ensuring their reliability for research and therapeutic use.

Pioneering Cardiomyocyte Differentiation for Advanced Applications

Following the acquisition of iPSC technology, First Stem Cell and Genomics Laboratory (FSG) has successfully advanced to the next vital stage—guiding pluripotent stem cells to differentiate into specialized cardiomyocytes.
Day - 01 Day 0 Day 4 Day 7 Day 10 Day 13

Preparation and Plating of iPSCs

The process begins by seeding high-quality iPSCs into a monolayer culture, setting the foundation for controlled differentiation. Cells are plated at an optimized density to promote even growth and minimize variability throughout the experiment.

Initiation of Differentiation Process

Differentiation is initiated by introducing a specialized differentiation medium that promotes mesoderm induction.

Early Lineage Commitment Assessment

Cells are monitored for early markers of lineage specification. Morphological changes and key genetic expressions are evaluated to confirm proper progression, ensuring fidelity in developmental cues and pathway activation.

Mid-Stage Differentiation Monitoring

At this stage, cells exhibit characteristic structures and marker expression profiles. The medium is adjusted to support further maturation while eliminating undifferentiated cells to enhance culture purity and stability.

Advanced Maturation and Validation

Cells begin acquiring more mature phenotypes and functions. Validation assays are conducted to assess differentiation accuracy, including marker analysis and functional behavior, ensuring readiness for downstream applications.

Final Characterization and Harvesting

Fully differentiated cells are characterized using morphological, genetic, and functional criteria. High-quality cells are harvested and prepared for research or therapeutic use, ensuring standardization and reproducibility of results.

Book Your Free Online Consultation

Book Your Free Online Consultation